Quanterix (QTRX) Net Cash Flow Growth (3y) (2020 - 2026)
Quanterix (QTRX) Net Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.00 Bn | 175.71 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.69 Bn | 125.81 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 47.97 Bn | 44.30 Bn | 1.29 Bn | -87.88% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.00 Bn | 1.98 Bn | -65.12% |
| 7 | Dexcom | 28.21 Bn | 27.09 Bn | 750.30 Mn | 129.29% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | -48.90% |
| 10 | Quanterix | 173.82 Mn | 74.56 Mn | 15.57 Mn | 38.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.88% |
| Dec 31, 2025 | -19.71% |
| Sep 30, 2025 | -73.22% |
| Jun 30, 2025 | 85.41% |
| Mar 31, 2025 | 42.25% |
| Dec 31, 2024 | 60.64% |
| Sep 30, 2024 | 3.15% |
| Jun 30, 2024 | 28.91% |
| Mar 31, 2024 | -35.58% |
| Dec 31, 2023 | -74.53% |
| Sep 30, 2023 | -52.08% |
| Jun 30, 2023 | 26.96% |
| Mar 31, 2023 | 9.62% |
| Dec 31, 2022 | -4.51% |
| Sep 30, 2022 | -34.57% |
| Jun 30, 2022 | -32.67% |
| Mar 31, 2022 | -27.41% |
| Dec 31, 2021 | -23.30% |
| Sep 30, 2021 | -35.10% |
| Jun 30, 2021 | -35.83% |